NovoSource’s implants use proven technology that has produced clinical trial results. However, it outsources the manufacturing and sells directly to hospitals and surgeons
The company’s first product, a total knee replacement, should be launched by the end of the first quarter of 2013, pending FDA approval. A hip implant will follow.
NovoSource was founded by Harold Linville, former chief business development officer at Leis Medical Manufacturing; Jon May, president at Latex International; and Bradley Harris, former CEO at Upex Holdings.
More Articles on Orthopedic & Spine Devices:
57 Orthopedic & Spine Devices Receive FDA 510(k) Clearance in October
Tornier Names David Mowry Interim President, CEO
Orthofix Announces International Launch of TrueLok Hexapod System
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.